CEACAM5 and colorectal cancer: After its identification as a tumor-specific marker for colorectal cancer in 1965 by Gold and Freedman, the carcinoembryonic antigen (CEA), later classified as CEACAM5, was the first of a wide family of CEACAMs to be discovered as important regulators in carcinogenesis (58).